重视帕金森病的正确诊断——帕金森病与帕金森综合征诊断及鉴别诊断的现代认识

[1] 额颞痴呆 [J]. 临床神经病学杂志, 2006, (03) : 228 - 230

[2] Olfactory loss may be a first sign of idiopathic Parkinson's disease [J]. MOVEMENT DISORDERS, 2007, 22 (06) : 839 - 842

[3] The diagnosis of Parkinson's disease [J]. LANCET NEUROLOGY, 2006, 5 (01) : 75 - 86

[4] Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology[J] . O Suchowersky,S Reich,J Perlmutter,T Zesiewicz,G Gronseth,W J. Weiner.Neurology . 2006 (7)

[5] REM sleep behavior disorder: A possible early marker for synucleinopathies[J] . Bradley F. Boeve,Clifford B. Saper.Neurology . 2006 (6)

[6] A common LRRK2 mutation in idiopathic Parkinson's disease[J] . William P Gilks,Patrick M Abou-Sleiman,Sonia Gandhi,Shushant Jain,Andrew Singleton,Andrew J Lees,Karen Shaw,Kailash P Bhatia,Vincenzo Bonifati,Niall P Quinn,John Lynch,Daniel G Healy,Janice L Holton,Tamas Revesz,Nicholas W Wood.The Lancet . 2005 (9457)

[7] Stages in the development of Parkinson's disease-related pathology [J]. CELL AND TISSUE RESEARCH, 2004, 318 (01) : 121 - 134

[8] Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis[J] . Jan C.M.Zijlmans,Susan E.Daniel,Andrew J.Hughes,TamasRévész,Andrew J.Lees.Mov. Disord. . 2004 (6)

[9] The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia[J] . Ann Neurol. . 2004 (2)

[10] Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study[J] . Alan L.Whone,Ray L.Watts,A. JonStoessl,MargaretDavis,SvenReske,ClaudeNahmias,Anthony E.Lang,OlivierRascol,Maria J.Ribeiro,PhilippeRemy,Werner H.Poewe,Robert A.Hauser,David J.Brooks.Ann Neurol. . 2003 (1)

[1] 额颞痴呆 [J]. 临床神经病学杂志, 2006, (03) : 228 - 230

[2] Olfactory loss may be a first sign of idiopathic Parkinson's disease [J]. MOVEMENT DISORDERS, 2007, 22 (06) : 839 - 842

[3] The diagnosis of Parkinson's disease [J]. LANCET NEUROLOGY, 2006, 5 (01) : 75 - 86

[4] Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology[J] . O Suchowersky,S Reich,J Perlmutter,T Zesiewicz,G Gronseth,W J. Weiner.Neurology . 2006 (7)

[5] REM sleep behavior disorder: A possible early marker for synucleinopathies[J] . Bradley F. Boeve,Clifford B. Saper.Neurology . 2006 (6)

[6] A common LRRK2 mutation in idiopathic Parkinson's disease[J] . William P Gilks,Patrick M Abou-Sleiman,Sonia Gandhi,Shushant Jain,Andrew Singleton,Andrew J Lees,Karen Shaw,Kailash P Bhatia,Vincenzo Bonifati,Niall P Quinn,John Lynch,Daniel G Healy,Janice L Holton,Tamas Revesz,Nicholas W Wood.The Lancet . 2005 (9457)

[7] Stages in the development of Parkinson's disease-related pathology [J]. CELL AND TISSUE RESEARCH, 2004, 318 (01) : 121 - 134

[8] Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis[J] . Jan C.M.Zijlmans,Susan E.Daniel,Andrew J.Hughes,TamasRévész,Andrew J.Lees.Mov. Disord. . 2004 (6)

[9] The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia[J] . Ann Neurol. . 2004 (2)

[10] Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study[J] . Alan L.Whone,Ray L.Watts,A. JonStoessl,MargaretDavis,SvenReske,ClaudeNahmias,Anthony E.Lang,OlivierRascol,Maria J.Ribeiro,PhilippeRemy,Werner H.Poewe,Robert A.Hauser,David J.Brooks.Ann Neurol. . 2003 (1)